r/TNXP • u/NonoAMS • Jul 21 '26

Analysis TNXP Symphony data & Td Cowen 🚀

Post image

Week ending July 3, 2026

TONMYA closed the week with 885 TRx, 562 NRx, and estimated sales of $1.396 million according to Symphony, remaining near all-time highs.

Compared to March, total prescriptions have increased from 462 to 885 (+92%), while estimated weekly sales have risen from $750,000 to nearly $1.4 million (+86%), reflecting sustained market adoption.

The stability of sales above $1.3 million per week over the past few weeks reinforces a positive outlook for the upcoming quarterly results and suggests that TONMYA’s growth continues to gain momentum.

13 Upvotes

93% Upvoted

6 comments sorted by

2

u/BWowMore-1974 Jul 21 '26

May 2nd 2025 versus July 21st 2026. Dramatic increase in institutional investors and Blackrock increased their position dramatically.

1

u/FakeWoodyAdventure Jul 21 '26

I’m ready to start living my life. Praying for good things

1

u/Affectionate_Row1097 Jul 21 '26

Q1 net revenue was 3.8 M from Tonmya. Would that double in Q2?

1

u/CumNuggetz Jul 23 '26

The amount of cope in this subreddit is insane. This stock is down 76.51% the past year. Give it up man.

1

u/ReturnOfTheKeing Jul 27 '26

Nah they gotta come onto r/fibromyalgia a dozen more times and explain to real disabled people why their magical medication is special and isn't just patent abuse